title: Activated RET oncogene products induce maturation of xenopus oocytes.
abstract: The RET proto-oncogene encodes a transmembrane receptor of the tyrosine kinase family, recently found to be the gene responsible for the multiple endocrine neoplasia type 2A and 2B syndromes. RET was found specifically activated, by gene rearrangement, in human thyroid carcinomas of the papillary subtype. In most cases the activation consisted of an in frame fusion of the RET tyrosine-kinase domain, at the carboxy-terminus, with heterologous genes at the amino-terminus. These chimeric oncogenes are collectively named RET/PTC. Two forms of these gene products, RET/PTC1 and RET/PTC3, have been tested for their ability to induce meiotic maturation in Xenopus oocytes. Injection of RET/PTC mRNAs into immature oocytes induced maturation-promoting-factor (MPF) activation and germinal vesicle breakdown (GVBD). The injected oocytes expressed polypeptides recognized by an anti-RET gene product antibody as well as by an antiphosphotyrosine antibody, indicating activation of the tyrosine-kinase domain. The RET/PTC induced maturation was dependent on endogenous ras; in fact, the coinjection of RET/PTC mRNA with a neutralizing anti-ras antibody blocked oocytes maturation without interfering with the accumulation and tyrosine-phosphorylation of the RET/PTC protein.
authors.affiliation: Institute of Cancer Research, Columbia University, New York, New York 10032, USA.
authors.forename: D
authors.initials: D
authors.lastname: Grieco
authors.forename: M
authors.initials: M
authors.lastname: Santoro
authors.forename: N A
authors.initials: NA
authors.lastname: Dathan
authors.forename: A
authors.initials: A
authors.lastname: Fusco
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal; D029721:Drosophila Proteins; D005260:Female; D006801:Humans; D007328:Insulin / Q000502:physiology; D016200:Maturation-Promoting Factor / Q000037:antagonists & inhibitors / Q000502:physiology; D015689:Oncogene Protein p21(ras) / Q000378:metabolism; D009865:Oocytes / Q000502:physiology*; D009866:Oogenesis / Q000502:physiology; D010766:Phosphorylation; D014176:Protein Biosynthesis; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology*; D051096:Proto-Oncogene Proteins c-ret; D012333:RNA, Messenger / Q000235:genetics; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics / Q000502:physiology*; D014443:Tyrosine / Q000378:metabolism; D014982:Xenopus laevis
chemical_list: D000911:Antibodies, Monoclonal; D029721:Drosophila Proteins; D007328:Insulin; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas; D011518:Proto-Oncogene Proteins; D012333:RNA, Messenger; D014443:Tyrosine; D051096:Proto-Oncogene Proteins c-ret; D020794:Receptor Protein-Tyrosine Kinases; C416649:Ret protein, Drosophila; D016200:Maturation-Promoting Factor; D015689:Oncogene Protein p21(ras)